Nicola
Nicola was diagnosed with ovarian cancer in July 2016 and participated in the 100,000 Genomes Project shortly after. Nicola’s son died of cancer in 2012 and she wanted her DNA to be used to help further cancer research. She provided blood and tissue samples for the genomes project but has since been told that it will not be included in the research.
Nicola agreed to take part in the 100,000 Genomes Project shortly after she was diagnosed with ovarian cancer in July 2016. Cancer research and its genetic basis are important to Nicola because her son died of cancer in 2012 and she is very interested in getting rid of this hideous monster that is cancer. Nicola thinks her son may have taken part in the study. Nicola is also interested in whether their family history has genetic implications for the health of her family.
Nicola was approached by researchers straight after an appointment with a consultant about her cancer treatment. The researchers explained what taking part in the genome study involved and reassured her she didn’t have to take part if she didn’t want to. Whilst Nicola found the decision to take part straightforward because of her son’s experience, she felt it would not be easy to say no, given patients are invited just before having surgery. Samples were taken during her cancer treatment and operation.
Nicola recently found out that her sample is not being included in the project. She has been told that she can phone a number to find out why but she is not inclined to bother. She wonders whether she had the wrong sort of cancer or that maybe the biopsy sample was not good enough to be included in the project.
Throughout the process, Nicola made it clear to the researchers that her only interest in the study was to help improve cancer research. She has very strong ethical concerns about the implications of genetic and genomic research for eradicating autism or Down’s syndrome; I think there is a big ethical debate that hasn’t been fully realised because people mix up disability or difference with disease.